Sparebanken More (FRA:K5X) Research & Development: €0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:K5X Sparebanken More FRA:K5X
59 GF Score
Price €9.45
GF Value €8.09
! 8 Warning Signs
View Full Analysis

What is Sparebanken More Research & Development?

Sparebanken More FRA:K5X +0.53% 59 Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:K5X with a GF Score™ of 59/100 and a GF Value™ of €8.09. The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Sparebanken More's Research & Development for the three months ended in Mar. 2026 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.0 Mil.

Sparebanken More  (FRA:K5X) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sparebanken More Research & Development Related Terms

Sparebanken More Research & Development Historical Data

* Premium members only.

The historical data trend for Sparebanken More's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sparebanken More Research & Development Chart

Sparebanken More Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sparebanken More Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:K5X
59GF Score
Sparebanken More FRA:K5X
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sparebanken More Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
Sparebanken More (FRA:K5X) has a Research & Development of €0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Sparebanken More and its competitors.
Is Sparebanken More's Research & Development too high?
Sparebanken More's current Research & Development is €0.0 Mil. Overall, Sparebanken More has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Sparebanken More's Research & Development compare to competitors?
Sparebanken More's Research & Development of €0.0 Mil can be compared against companies in the Banks industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Banks company?
A good Research & Development depends on the Banks industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Sparebanken More and its competitors. Sparebanken More's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sparebanken More stock overvalued right now?
Sparebanken More (FRA:K5X) has a current Research & Development of €0.0 Mil. The stock's GF Value™ is €8.09, compared to a current price of €9.45 — trading 16.8% above its estimated fair value. The current Research & Development is €0.0 Mil. Sparebanken More's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Sparebanken More (FRA:K5X), the current Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sparebanken More (FRA:K5X) Overvalued in 2026?

Based on GuruFocus' analysis, Sparebanken More stock appears to be overvalued. The current stock price of €9.45 is trading 16.8% above its estimated GF Value™ of €8.09.

Key valuation signals for FRA:K5X:

  • Research & Development: €0.0 Mil
  • GF Value™: €8.09 vs. price of €9.45 (16.8% above fair value)
  • GF Score™: 59/100 with 8 warning signs

No single metric tells the full story. See the FRA:K5X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sparebanken More Business Description

Other Exchanges MORG:Norway0G40:UK
Address Kipervikgata 6, Alesund, NOR, 6003
Sparebanken Møre is a Norway-based banking corporation. It engaged in providing retail and commercial banking services to its customers. Products and services provided by the company include deposits, savings accounts, asset management, financial advisory services, payment transfers, foreign exchange and interest trading, insurance, and real estate brokerage. In addition, the company also provides real estate brokerage services for both residential homes and commercial properties. It mainly concentrates on maritime, offshore and supply, real estate, trade, and services, as well as the insurance industries. It firm manages its business into three segments: Corporate, Retail, and Real Estate brokerage. The revenue of the company comprises interest, fees, commission, and other income.
59GF Score

Get the complete analysis for FRA:K5X

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.45
Price
€8.09
GF Value